13F filer · CIK 1056807
BVF INC/IL
San Francisco, CA · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$3.9B
+$772.0M vs prior
Positions
44
New / sold out
7 / 4
Added / reduced
6 / 8
Turnover
10.2%
buys $360.8M · sells $421.1M
Top-10 weight
65.6%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | XOMA ROYALTY CORPORATION | +5,003,000 | +193.1% | +$212.6M |
| New | Q32 BIO INC | +2,350,000 | – | +$29.9M |
| New | ABSCI CORPORATION | +2,361,674 | – | +$27.4M |
| Added | REVOLUTION MEDICINES INC | +108,378 | +3.8% | +$20.3M |
| New | SAGIMET BIOSCIENCES INC | +2,500,000 | – | +$19.3M |
| New | IMMUNIC INC | +765,295 | – | +$11.8M |
| Added | AVALO THERAPEUTICS INC | +442,700 | +27.1% | +$8.2M |
| Added | ALKERMES PLC | +154,704 | +7.7% | +$8.1M |
| Added | INVIVYD INC | +8,640,000 | +44.3% | +$7.5M |
| Added | ONKURE THERAPEUTICS INC | +1,256,806 | +63.5% | +$5.7M |
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | KYMERA THERAPEUTICS INC | -1,630,658 | -29.6% | $-187.0M |
| Reduced | MIRUM PHARMACEUTICALS INC | -528,700 | -33.4% | $-61.9M |
| Reduced | PALVELLA THERAPEUTICS INC NE | -288,200 | -30.0% | $-44.0M |
| Sold out | COMPASS THERAPEUTICS INC | -7,764,842 | -100.0% | $-41.1M |
| Sold out | SEPTERNA INC | -1,353,249 | -100.0% | $-32.5M |
| Reduced | TYRA BIOSCIENCES INC | -500,000 | -25.3% | $-16.0M |
| Reduced | NEKTAR THERAPEUTICS | -168,520 | -6.6% | $-11.8M |
| Reduced | DISC MEDICINE INC | -118,700 | -9.3% | $-8.7M |
| Sold out | IMMUNIC INC | -7,652,972 | -100.0% | $-8.5M |
| Reduced | STRUCTURE THERAPEUTICS INC | -92,535 | -2.7% | $-5.0M |
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INCCOM | 2,965,160 | $555.3M | 14.20% |
| 2 | KYMERA THERAPEUTICS INCCOM | 3,872,052 | $444.0M | 11.35% |
| 3 | XOMA ROYALTY CORPORATIONCOM NEW | 7,593,303 | $322.7M | 8.25% |
| 4 | MOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD | 16,001,284 | $311.5M | 7.97% |
| 5 | GH RESEARCH PLCORDINARY SHARES | 8,650,158 | $232.5M | 5.95% |
| 6 | STRUCTURE THERAPEUTICS INCSPONSORED ADS | 3,366,823 | $180.7M | 4.62% |
| 7 | NEKTAR THERAPEUTICSCOM NEW | 2,391,075 | $166.9M | 4.27% |
| 8 | MIRUM PHARMACEUTICALS INCCOM | 1,056,027 | $123.6M | 3.16% |
| 9 | XENCOR INCCOM | 7,133,720 | $114.9M | 2.94% |
| 10 | ALKERMES PLCSHS | 2,154,704 | $112.9M | 2.89% |
34 more rows. Subscribe for $29/month to see every row, download the data and use the API.